103933-03-5Relevant articles and documents
HYDROXYNORKETAMINE DERIVATIVES FOR THE TREATMENT OF CNS DISORDERS
-
, (2018/03/25)
Chemical entities of Formula (I): Including enantiomers thereof, wherein R1 has any of the values described herein, and compositions comprising such chemical entities; their preparation; and their use in various methods, including the treatment of depression, pain, cognitive disorders, neurodegenerative disorders, and other neurological and peripheral disorders.
Comparative pharmacology in the rat of ketamine and its two principal metabolites, norketamine and (Z)-6-hydroxynorketamine
Leung,Baillie
, p. 2396 - 2399 (2007/10/02)
-